The electrophysiological development of cardiomyocytes

Advanced Drug Delivery Reviews

Volumn 96, Issue , 2016, Pages 253-273

  Liu, Jie ^a   Laksman, Zachary ^b   Backx, Peter H ^c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d YORK UNIVERSITY   (Canada)

Author keywords

Cardiomyocyte; Heart development; Heart electrophysiology; Human stem cells; Ion channel

Indexed keywords

CARDIOLOGY; CELL CULTURE; CELLS; CYTOLOGY; DIAGNOSIS; DISEASES; ELECTROPHYSIOLOGY; HEART;

CARDIAC DISEASE; CARDIAC REGENERATION; CARDIOMYOCYTES; FUNCTIONAL PROPERTIES; FUTURE APPLICATIONS; HEART DEVELOPMENT; ION CHANNEL; PLURIPOTENT STEM CELLS;

STEM CELLS;

4 (N ETHYL N PHENYLAMINO) 1,2 DIMETHYL 6 (METHYLAMINO)PYRIMIDINIUM CHLORIDE; AMLODIPINE; DILTIAZEM; FLECAINIDE; ION CHANNEL; NIFEDIPINE; PHENYLALKYLAMINE; PROPAFENONE; RANOLAZINE;

ACTION POTENTIAL AMPLITUDE; ACTION POTENTIAL DURATION; ADRENERGIC STIMULATION; ANTIARRHYTHMIC ACTIVITY; ATRIAL FIBRILLATION; CALCIUM CURRENT; CARDIAC MUSCLE CELL; CHOLINERGIC STIMULATION; DRUG TARGETING; EMBRYONIC STEM CELL; HEART ARRHYTHMIA; HEART ATRIUM; HEART DEVELOPMENT; HEART ELECTROPHYSIOLOGY; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART RATE; HEART VENTRICLE; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; POTASSIUM CURRENT; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SODIUM CURRENT; ACTION POTENTIAL; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE TECHNIQUE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECTS; GENETICS; HEART; HEART CONTRACTION; HEART FUNCTION TEST; PHYSIOLOGY; PRECLINICAL STUDY; PROCEDURES; TISSUE ENGINEERING;

ACTION POTENTIALS; ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; DRUG EVALUATION, PRECLINICAL; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HEART; HEART RATE; HUMANS; ION CHANNELS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; TISSUE ENGINEERING;

EID: 84955325728     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2015.12.023     Document Type: Review

References (283)

1. [1] Laslett, L.J., Alagona, P. Jr., Clark, B.A. 3rd, Drozda, J.P. Jr., Saldivar, F., Wilson, S.R., Poe, C., Hart, M., The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American college of cardiology. J. Am. Coll. Cardiol. 60 (2012), S1–49.
2. [2] Loscalzo, J., Personalized cardiovascular medicine and drug development time for a new paradigm. Circulation 125 (2012), 638–645.
3. [3] Lelovas, P.P., Kostomitsopoulos, N.G., Xanthos, T.T., A comparative anatomic and physiologic overview of the porcine heart. J. Am. Assoc. Lab. Anim. Sci. 53 (2014), 432–438.
4. [4] Hasenfuss, G., Animal models of human cardiovascular disease, heart failure and hypertrophy. Cardiovasc. Res. 39 (1998), 60–76.
5. [5] Matsa, E., Sallam, K., Wu, J.C., Cardiac stem cell biology: glimpse of the past, present, and future. Circ. Res. 114 (2014), 21–27.
6. [6] Moretti, A., Bellin, M., Welling, A., Jung, C.B., Lam, J.T., Bott-Flugel, L., Dorn, T., Goedel, A., Hohnke, C., Hofmann, F., Seyfarth, M., Sinnecker, D., Schomig, A., Laugwitz, K.L., Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363 (2010), 1397–1409.
7. [7] Kim, C., Wong, J., Wen, J., Wang, S., Wang, C., Spiering, S., Kan, N.G., Forcales, S., Puri, P.L., Leone, T.C., Marine, J.E., Calkins, H., Kelly, D.P., Judge, D.P., Chen, H.S., Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature 494 (2013), 105–110.
8. [8] van den Heuvel, N.H., van Veen, T.A., Lim, B., Jonsson, M.K., Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes. J. Mol. Cell. Cardiol. 67 (2014), 12–25.
9. [9] Paige, S.L., Plonowska, K., Xu, A., Wu, S.M., Molecular regulation of cardiomyocyte differentiation. Circ. Res. 116 (2015), 341–353.
10. [10] Douglas, J.J., Zipes, P., Cardiac Electrophysiology: From Cell to Bedside. 2014.
11. [11] Schram, G., Pourrier, M., Melnyk, P., Nattel, S., Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function. Circ. Res. 90 (2002), 939–950.
12. [12] Lopatin, A.N., Nichols, C.G., Inward rectifiers in the heart: an update on I(K1). J. Mol. Cell. Cardiol. 33 (2001), 625–638.
13. [13] Sicouri, S., Antzelevitch, C., A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. Circ. Res. 68 (1991), 1729–1741.
14. [14] Dangman, K.H., Danilo, P., Hordof, A.J., Maryrabine, L., Reder, R.F., Rosen, M.R., Electrophysiologic characteristics of human ventricular and Purkinje-fibers. Circulation 65 (1982), 362–368.
15. [15] Remme, C.A., Verkerk, A.O., Hoogaars, W.M., Aanhaanen, W.T., Scicluna, B.P., Annink, C., van den Hoff, M.J., Wilde, A.A., van Veen, T.A., Veldkamp, M.W., de Bakker, J.M., Christoffels, V.M., Bezzina, C.R., The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium. Basic Res. Cardiol. 104 (2009), 511–522.
16. [16] Wang, Z., Fermini, B., Nattel, S., Delayed rectifier outward current and repolarization in human atrial myocytes. Circ. Res. 73 (1993), 276–285.
17. [17] Nabauer, M., Beuckelmann, D.J., Uberfuhr, P., Steinbeck, G., Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation 93 (1996), 168–177.
18. [18] Huang, F., Wong, X., Jan, L.Y., International union of basic and clinical pharmacology. LXXXV: calcium-activated chloride channels. Pharmacol. Rev. 64 (2012), 1–15.
19. [19] Oudit, G.Y., Kassiri, Z., Sah, R., Ramirez, R.J., Zobel, C., Backx, P.H., The molecular physiology of the cardiac transient outward potassium current (I(to)) in normal and diseased myocardium. J. Mol. Cell. Cardiol. 33 (2001), 851–872.
20. [20] Nerbonne, J.M., Nichols, C.G., Schwarz, T.L., Escande, D., Genetic manipulation of cardiac K(+) channel function in mice: what have we learned, and where do we go from here?. Circ. Res. 89 (2001), 944–956.
21. [21] Han, W., Bao, W., Wang, Z., Nattel, S., Comparison of ion-channel subunit expression in canine cardiac Purkinje fibers and ventricular muscle. Circ. Res. 91 (2002), 790–797.
22. [22] Perrin, M.J., Adler, A., Green, S., Al-Zoughool, F., Doroshenko, P., Orr, N., Uppal, S., Healey, J.S., Birnie, D., Sanatani, S., Gardner, M., Champagne, J., Simpson, C., Ahmad, K., van den Berg, M.P., Chauhan, V., Backx, P.H., van Tintelen, J.P., Krahn, A.D., Gollob, M.H., Evaluation of genes encoding for the transient outward current (Ito) identifies the KCND2 gene as a cause of J-wave syndrome associated with sudden cardiac death. Circ. Cardiovasc. Genet. 7 (2014), 782–789.
23. [23] Ramirez, R.J., Sah, R., Liu, J., Rose, R.A., Backx, P.H., Intracellular [Na(+)] modulates synergy between Na(+)/Ca (2 +) exchanger and L-type Ca (2 +) current in cardiac excitation–contraction coupling during action potentials. Basic Res. Cardiol. 106 (2011), 967–977.
24. [24] Di Diego, J.M., Sun, Z.Q., Antzelevitch, C., I(to) and action potential notch are smaller in left vs. right canine ventricular epicardium. Am. J. Phys. 271 (1996), H548–H561.
25. [25] Nerbonne, J.M., Kass, R.S., Molecular physiology of cardiac repolarization. Physiol. Rev. 85 (2005), 1205–1253.
26. [26] Thomas, G.P., Gerlach, U., Antzelevitch, C., HMR 1556, a potent and selective blocker of slowly activating delayed rectifier potassium current. J. Cardiovasc. Pharmacol. 41 (2003), 140–147.
27. [27] Gerlach, U., Blockers of the slowly delayed rectifier potassium IKs channel: potential antiarrhythmic agents. Curr. Med. Chem. Cardiovasc. Hematol. Agents 1 (2003), 243–252.
28. [28] Maier, L.S., Sossalla, S., The late Na current as a therapeutic target: where are we?. J. Mol. Cell. Cardiol. 61 (2013), 44–50.
29. [29] Suto, F., Zhu, W., Chan, A., Gross, G.J., IKr and IKs remodeling differentially affects QT interval prolongation and dynamic adaptation to heart rate acceleration in bradycardic rabbits. Am. J. Physiol. Heart Circ. Physiol. 292 (2007), H1782–H1788.
30. [30] Gintant, G.A., Two components of delayed rectifier current in canine atrium and ventricle. Does IKs play a role in the reverse rate dependence of class III agents?. Circ. Res. 78 (1996), 26–37.
31. [31] Tseng, G.N., I(Kr): the hERG channel. J. Mol. Cell. Cardiol. 33 (2001), 835–849.
32. [32] Izumi-Nakaseko, H., Nakamura, Y., Cao, X., Ohara, H., Yamazaki, Y., Ueda, N., Ando, K., Sugiyama, A., Effects of selective IKr channel blockade by E-4031 on ventricular electro-mechanical relationship in the halothane-anesthetized dogs. Eur. J. Pharmacol. 740 (2014), 263–270.
33. [33] Brown, E.M., Watson, E.J., Thatcher, J.G., Koletsky, R., Dawsonhughes, B.F., Posillico, J.T., Shoback, D.M., Ouabain and low extracellular potassium inhibit Pth secretion from bovine parathyroid cells by a mechanism that does not involve increases in the cytosolic calcium-concentration. Metabolism 36 (1987), 36–42.
34. [34] Nitabach, M.N., Llamas, D.A., Araneda, R.C., Intile, J.L., Thompson, I.J., Zhou, Y.I., Holmes, T.C., A mechanism for combinatorial regulation of electrical activity: potassium channel subunits capable of functioning as Src homology 3-dependent adaptors. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 705–710.
35. [35] Bryant, S.M., Wan, X., Shipsey, S.J., Hart, G., Regional differences in the delayed rectifier current (IKr and IKs) contribute to the differences in action potential duration in basal left ventricular myocytes in guinea-pig. Cardiovasc. Res. 40 (1998), 322–331.
36. [36] Limberis, J.T., Su, Z., Cox, B.F., Gintant, G.A., Martin, R.L., Altering extracellular potassium concentration does not modulate drug block of human ether-a-go-go-related gene (hERG) channels. Clin. Exp. Pharmacol. Physiol. 33 (2006), 1059–1065.
37. [37] Eldstrom, J., Wang, Z., Xu, H., Pourrier, M., Ezrin, A., Gibson, K., Fedida, D., The molecular basis of high-affinity binding of the antiarrhythmic compound vernakalant (RSD1235) to Kv1.5 channels. Mol. Pharmacol. 72 (2007), 1522–1534.
38. + channel. J. Gen. Physiol. 99 (1992), 961–983.
39. + channel in heart. Nature 325 (1987), 321–326.
40. [40] Giles, W.R., Imaizumi, Y., Comparison of potassium currents in rabbit atrial and ventricular cells. J. Physiol. 405 (1988), 123–145.
41. [41] Wang, Z., Yue, L., White, M., Pelletier, G., Nattel, S., Differential distribution of inward rectifier potassium channel transcripts in human atrium versus ventricle. Circulation 98 (1998), 2422–2428.
42. 2 + channels in the heart. J. Mol. Cell. Cardiol. 48 (2010), 65–70.
43. [43] Nattel, S., Calcium-activated potassium current: a novel ion channel candidate in atrial fibrillation. J. Physiol. Lond. 587 (2009), 1385–1386.
44. [44] Zygmunt, A.C., Gibbons, W.R., Properties of the calcium-activated chloride current in heart. J. Gen. Physiol. 99 (1992), 391–414.
45. [45] Qi, X.Y., Diness, J.G., Brundel, B.J., Zhou, X.B., Naud, P., Wu, C.T., Huang, H., Harada, M., Aflaki, M., Dobrev, D., Grunnet, M., Nattel, S., Role of small-conductance calcium-activated potassium channels in atrial electrophysiology and fibrillation in the dog. Circulation 129 (2014), 430–440.
46. [46] DiFrancesco, D., Pacemaker mechanisms in cardiac tissue. Annu. Rev. Physiol. 55 (1993), 455–472.
47. [47] Irisawa, H., Brown, H.F., Giles, W., Cardiac pacemaking in the sinoatrial node. Physiol. Rev. 73 (1993), 197–227.
48. [48] Zhang, Z., He, Y., Tuteja, D., Xu, D., Timofeyev, V., Zhang, Q., Glatter, K.A., Xu, Y., Shin, H.S., Low, R., Chiamvimonvat, N., Functional roles of Cav1.3(alpha1D) calcium channels in atria: insights gained from gene-targeted null mutant mice. Circulation 112 (2005), 1936–1944.
49. [49] Wiese, C., Grieskamp, T., Airik, R., Mommersteeg, M.T., Gardiwal, A., Vries, C.d.G.-d., Schuster-Gossler, K., Moorman, A.F., Kispert, A., Christoffels, V.M., Formation of the sinus node head and differentiation of sinus node myocardium are independently regulated by Tbx18 and Tbx3. Circ. Res. 104 (2009), 388–397.
50. [50] Kumar, N.M., Gilula, N.B., The gap junction communication channel. Cell 84 (1996), 381–388.
51. [51] Hof, T., Simard, C., Rouet, R., Salle, L., Guinamard, R., Implication of the TRPM4 nonselective cation channel in mammalian sinus rhythm. Heart Rhythm.: Off. J. Heart Rhythm Soc. 10 (2013), 1683–1689.
52. [52] Verkerk, A.O., Wilders, R., van Borren, M.M., Peters, R.J., Broekhuis, E., Lam, K., Coronel, R., de Bakker, J.M., Tan, H.L., Pacemaker current (I(f)) in the human sinoatrial node. Eur. Heart J. 28 (2007), 2472–2478.
53. [53] Stillitano, F., Lonardo, G., Zicha, S., Varro, A., Cerbai, E., Mugelli, A., Nattel, S., Molecular basis of funny current (I-f) in normal and failing human heart. J. Mol. Cell. Cardiol. 45 (2008), 289–299.
54. [54] Maltsev, V.A., Vinogradova, T.M., Bogdanov, K.Y., Lakatta, E.G., Stern, M.D., Diastolic calcium release controls the beating rate of rabbit sinoatrial node cells: numerical modeling of the coupling process. Biophys. J. 86 (2004), 2596–2605.
55. [55] Ono, K., Shibata, S., Iijima, T., Properties of the delayed rectifier potassium current in porcine Sino-atrial node cells. J. Physiol. 524:Pt 1 (2000), 51–62.
56. + channel in rabbit sinoatrial node cells. Am. J. Physiol. 269 (1995), H443–H452.
57. [57] Verkerk, A.O., van Borren, M.M., Peters, R.J., Broekhuis, E., Lam, K.Y., Coronel, R., de Bakker, J.M., Tan, H.L., Wilders, R., Single cells isolated from human sinoatrial node: action potentials and numerical reconstruction of pacemaker current, conference proceedings: annual international conference of the IEEE engineering in medicine and biology society. IEEE Engineering in Medicine and Biology Society Annual Conference, 2007, 2007, 904–907.
58. + current in pacemaker cells isolated from rabbit sinoatrial node. Am. J. Physiol. 270 (1996), H2108–H2119.
59. [59] Baruscotti, M., Robinson, R.B., Electrophysiology and pacemaker function of the developing sinoatrial node. Am. J. Physiol. Heart Circ. Physiol. 293 (2007), H2613–H2623.
60. [60] Arechiga-Figueroa, I.A., Rodriguez-Martinez, M., Sanchez-Chapula, J.A., Voltage-dependent potassium currents in feline sino-atrial node myocytes. Pflugers Arch. - Eur. J. Physiol. 462 (2011), 385–396.
61. [61] Ono, K., Shibata, S., Iijima, T., Properties of the delayed rectifier potassium current in porcine sino-atrial node cells. J. Physiol. 524 (2000), 51–62.
62. [62] Verheijck, E.E., van Ginneken, A.C., Bourier, J., Bouman, L.N., Effects of delayed rectifier current blockade by E-4031 on impulse generation in single sinoatrial nodal myocytes of the rabbit. Circ. Res. 76 (1995), 607–615.
63. [63] Dobrzynski, H., Rothery, S.M., Marples, D.D., Coppen, S.R., Takagishi, Y., Honjo, H., Tamkun, M.M., Henderson, Z., Kodama, I., Severs, N.J., Boyett, M.R., Presence of the Kv1.5 K(+) channel in the sinoatrial node. J. Histochem. Cytochem.: Off. J. Histochem. Soc. 48 (2000), 769–780.
64. [64] DiFrancesco, D., The role of the funny current in pacemaker activity. Circ. Res. 106 (2010), 434–446.
65. [65] Csepe, T.A., Kalyanasundaram, A., Hansen, B.J., Zhao, J.C., Fedorov, V.V., Fibrosis: A Structural Modulator of Sinoatrial Node Physiology and Dysfunction, Frontiers in Physiology. 6, 2015.
66. [66] Monfredi, O., Dobrzynski, H., Mondal, T., Boyett, M.R., Morris, G.M., The anatomy and physiology of the sinoatrial node—a contemporary review. Pace 33 (2010), 1392–1406.
67. [67] Gros, D., Theveniau-Ruissy, M., Bernard, M., Calmels, T., Kober, F., Sohl, G., Willecke, K., Nargeot, J., Jongsma, H.J., Mangoni, M.E., Connexin 30 is expressed in the mouse sino-atrial node and modulates heart rate. Cardiovasc. Res. 85 (2010), 45–55.
68. [68] Dobrzynski, H., Boyett, M.R., Anderson, R.H., New insights into pacemaker activity — promoting understanding of sick sinus syndrome. Circulation 115 (2007), 1921–1932.
69. [69] Verheijck, E.E., van Kempen, M.J.A., Veereschild, M., Lurvink, J., Jongsma, H.J., Bouman, L.N., Electrophysiological features of the mouse sinoatrial node in relation to connexin distribution. Cardiovasc. Res. 52 (2001), 40–50.
70. [70] Litovsky, S.H., Antzelevitch, C., Transient outward current prominent in canine ventricular epicardium but not endocardium. Circ. Res. 62 (1988), 116–126.
71. [71] Sah, R., Ramirez, R.J., Oudit, G.Y., Gidrewicz, D., Trivieri, M.G., Zobel, C., Backx, P.H., Regulation of cardiac excitation–contraction coupling by action potential repolarization: role of the transient outward potassium current (I(to)). J. Physiol. 546 (2003), 5–18.
72. [72] Wendel, J.S., Ye, L., Tao, R., Zhang, J., Kamp, T.J., Tranquillo, R.T., Functional effects of a tissue-engineered cardiac patch from human induced pluripotent stem cell-derived cardiomyocytes in a rat infarct model. Stem Cells Transl. Med. 4 (2015), 1324–1332.
73. [73] Blazeski, A., Zhu, R., Hunter, D.W., Weinberg, S.H., Boheler, K.R., Zambidis, E.T., Tung, L., Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells. Prog. Biophys. Mol. Biol. 110 (2012), 178–195.
74. [74] Couch, J.R., West, T.C., Hoff, H.E., Development of the action potential of the prenatal rat heart. Circ. Res. 24 (1969), 19–31.
75. [75] Stieber, J., Herrmann, S., Feil, S., Loster, J., Feil, R., Biel, M., Hofmann, F., Ludwig, A., The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 15235–15240.
76. [76] Leiva, M.C., Tolosa, J.E., Binotto, C.N., Weiner, S., Huppert, L., Denis, A.L., Huhta, J.C., Fetal cardiac development and hemodynamics in the first trimester. Ultrasound Obstet. Gynecol. Off. J. Int. Soc. Ultrasound Obstret. Gynecol. 14 (1999), 169–174.
77. [77] Danielsson, C., Brask, J., Skold, A.C., Genead, R., Andersson, A., Andersson, U., Stockling, K., Pehrson, R., Grinnemo, K.H., Salari, S., Hellmold, H., Danielsson, B., Sylven, C., Elinder, F., Exploration of human, rat, and rabbit embryonic cardiomyocytes suggests K-channel block as a common teratogenic mechanism. Cardiovasc. Res. 97 (2013), 23–32.
78. [78] Christoffels, V.M., Smits, G.J., Kispert, A., Moorman, A.F., Development of the pacemaker tissues of the heart. Circ. Res. 106 (2010), 240–254.
79. [79] Vincent, S.D., Buckingham, M.E., How to make a heart: the origin and regulation of cardiac progenitor cells. Curr. Top. Dev. Biol. 90 (2010), 1–41.
80. 2 + release in spontaneous activity of ventricular cardiomyocytes during murine embryonic development. J. Cell. Biochem. 114 (2013), 1852–1862.
81. [81] Yasui, K., Liu, W., Opthof, T., Kada, K., Lee, J.K., Kamiya, K., Kodama, I., I(f) current and spontaneous activity in mouse embryonic ventricular myocytes. Circ. Res. 88 (2001), 536–542.
82. [82] Jezek, K., Pucelik, P., Sauer, J., Bartak, F., Basic electrophysiological parameters and frequency sensitivity of the ventricular myocardium of human embryos. Physiol. Bohemoslov. 31 (1982), 11–19.
83. [83] Wang, Y., Xu, H., Kumar, R., Tipparaju, S.M., Wagner, M.B., Joyner, R.W., Differences in transient outward current properties between neonatal and adult human atrial myocytes. J. Mol. Cell. Cardiol. 35 (2003), 1083–1092.
84. [84] Zhu, W.Z., Xie, Y.H., Moyes, K.W., Gold, J.D., Askari, B., Laflamme, M.A., Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells. Circ. Res., 107, 2010 776-U258.
85. [85] Zhang, J.H., Wilson, G.F., Soerens, A.G., Koonce, C.H., Yu, J.Y., Palecek, S.P., Thomson, J.A., Kamp, T.J., Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104 (2009), E30–E41.
86. [86] Reppel, M., Boettinger, C., Hescheler, J., Beta-adrenergic and muscarinic modulation of human embryonic stem cell-derived cardiomyocytes. Cell. Physiol. Biochem. 14 (2004), 187–196.
87. [87] Bett, G.C., Kaplan, A.D., Lis, A., Cimato, T.R., Tzanakakis, E.S., Zhou, Q., Morales, M.J., Rasmusson, R.L., Electronic “expression” of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells. Heart Rhythm. Off. J. Heart Rhythm Soc. 10 (2013), 1903–1910.
88. [88] Dangman, K.H., Danilo, P. Jr., Hordof, A.J., Mary-Rabine, L., Reder, R.F., Rosen, M.R., Electrophysiologic characteristics of human ventricular and Purkinje fibers. Circulation 65 (1982), 362–368.
89. [89] Li, G.R., Lau, C.P., Leung, T.K., Nattel, S., Ionic current abnormalities associated with prolonged action potentials in cardiomyocytes from diseased human right ventricles. Heart Rhythm. Off. J. Heart Rhythm Soc. 1 (2004), 460–468.
90. [90] Suffredini, S., Cerbai, E., Giunti, G., El Mouelhi, M., Pfannkuche, H.J., Mugelli, A., Electrophysiological characterization of isolated human atrial myocytes exposed to tegaserod. Basic Clin. Pharmacol. Toxicol. 106 (2010), 416–421.
91. [91] Zhang, J., Wilson, G.F., Soerens, A.G., Koonce, C.H., Yu, J., Palecek, S.P., Thomson, J.A., Kamp, T.J., Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104 (2009), e30–e41.
92. [92] Pekkanen-Mattila, M., Chapman, H., Kerkela, E., Suuronen, R., Skottman, H., Koivisto, A.P., Aalto-Setala, K., Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype. Exp. Biol. Med. (Maywood) 235 (2010), 522–530.
93. [93] Satin, J., Kehat, I., Caspi, O., Huber, I., Arbel, G., Itzhaki, I., Magyar, J., Schroder, E.A., Perlman, I., Gepstein, L., Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J. Physiol. 559 (2004), 479–496.
94. [94] O'Hara, T., Virag, L., Varro, A., Rudy, Y., Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation. PLoS Comput. Biol., 7, 2011, e1002061.
95. [95] D.K. Lieu, J.D. Fu, N. Chiamvimonvat, K.C. Tung, G.P. McNerney, T. Huser, G. Keller, C.W. Kong, R.A. Li, Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes, Circ. Arrhythm. Electrophysiol., 6 (2013) 191–201.
96. [96] Jonsson, M.K., Vos, M.A., Mirams, G.R., Duker, G., Sartipy, P., de Boer, T.P., van Veen, T.A., Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG. J. Mol. Cell. Cardiol. 52 (2012), 998–1008.
97. [97] Arnold, L., Page, J., Attwell, D., Cannell, M., Eisner, D.A., The dependence on heart rate of the human ventricular action potential duration. Cardiovasc. Res. 16 (1982), 547–551.
98. [98] Rohr, S., Role of gap junctions in the propagation of the cardiac action potential. Cardiovasc. Res. 62 (2004), 309–322.
99. [99] Sheng, X., Reppel, M., Nguemo, F., Mohammad, F.I., Kuzmenkin, A., Hescheler, J., Pfannkuche, K., Human pluripotent stem cell-derived cardiomyocytes: response to TTX and lidocain reveals strong cell to cell variability. PLoS One, 7, 2012, e45963.
100. [100] Pillekamp, F., Haustein, M., Khalil, M., Emmelheinz, M., Nazzal, R., Adelmann, R., Nguemo, F., Rubenchyk, O., Pfannkuche, K., Matzkies, M., Reppel, M., Bloch, W., Brockmeier, K., Hescheler, J., Contractile properties of early human embryonic stem cell-derived cardiomyocytes: beta-adrenergic stimulation induces positive chronotropy and lusitropy but not inotropy. Stem Cells Dev. 21 (2012), 2111–2121.
101. [101] Devalla, H.D., Schwach, V., Ford, J.W., Milnes, J.T., El-Haou, S., Jackson, C., Gkatzis, K., Elliott, D.A., Lopes, S.M.C.d.S., Mummery, C.L., Verkerk, A.O., Passier, R., Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology. EMBO Mol. Med. 7 (2015), 394–410.
102. [102] Mummery, C., Ward-van Oostwaard, D., Doevendans, P., Spijker, R., van den Brink, S., Hassink, R., van der Heyden, M., Opthof, T., Pera, M., de la Riviere, A.B., Passier, R., Tertoolen, L., Differentiation of human embryonic stem cells to cardiomyocytes — role of coculture with visceral endoderm-like cells. Circulation 107 (2003), 2733–2740.
103. [103] Chandler, N.J., Greener, I.D., Tellez, J.O., Inada, S., Musa, H., Molenaar, P., Difrancesco, D., Baruscotti, M., Longhi, R., Anderson, R.H., Billeter, R., Sharma, V., Sigg, D.C., Boyett, M.R., Dobrzynski, H., Molecular architecture of the human sinus node: insights into the function of the cardiac pacemaker. Circulation 119 (2009), 1562–1575.
104. [104] Chen, F., Klitzner, T.S., Weiss, J.N., Autonomic regulation of calcium cycling in developing embryonic mouse hearts. Cell Calcium 39 (2006), 375–385.
105. [105] Zhu, W.Z., Xie, Y., Moyes, K.W., Gold, J.D., Askari, B., Laflamme, M.A., Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells. Circ. Res. 107 (2010), 776–786.
106. [106] Haufe, V., Camacho, J.A., Dumaine, R., Gunther, B., Bollensdorff, C., von Banchet, G.S., Benndorf, K., Zimmer, T., Expression pattern of neuronal and skeletal muscle voltage-gated Na + channels in the developing mouse heart. J. Physiol. 564 (2005), 683–696.
107. [107] Kaufmann, S.G., Westenbroek, R.E., Zechner, C., Maass, A.H., Bischoff, S., Muck, J., Wischmeyer, E., Scheuer, T., Maier, S.K., Functional protein expression of multiple sodium channel alpha- and beta-subunit isoforms in neonatal cardiomyocytes. J. Mol. Cell. Cardiol. 48 (2010), 261–269.
108. [108] Kirchhof, P., Tal, T., Fabritz, L., Klimas, J., Nesher, N., Schulte, J.S., Ehling, P., Kanyshkova, T., Budde, T., Nikol, S., Fortmueller, L., Stallmeyer, B., Muller, F.U., Schulze-Bahr, E., Schmitz, W., Zlotkin, E., Kirchhefer, U., First report on an inotropic peptide activating tetrodotoxin-sensitive, “neuronal” sodium currents in the heart. Circ. Heart Fail. 8 (2015), 79–88.
109. [109] Schneider, M., Proebstle, T., Hombach, V., Hannekum, A., Rudel, R., Characterization of the sodium currents in isolated human cardiocytes. Pflugers Arch. - Eur. J. Physiol. 428 (1994), 84–90.
110. [110] Sakakibara, Y., Wasserstrom, J.A., Furukawa, T., Jia, H., Arentzen, C.E., Hartz, R.S., Singer, D.H., Characterization of the sodium current in single human atrial myocytes. Circ. Res. 71 (1992), 535–546.
111. [111] Goldin, A.L., Resurgence of sodium channel research. Annu. Rev. Physiol. 63 (2001), 871–894.
112. [112] Remme, C.A., Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects. J. Physiol. 591 (2013), 4099–4116.
113. [113] Makiyama, T., Akao, M., Tsuji, K., Doi, T., Ohno, S., Takenaka, K., Kobori, A., Ninomiya, T., Yoshida, H., Takano, M., Makita, N., Yanagisawa, F., Higashi, Y., Takeyama, Y., Kita, T., Horie, M., High risk for bradyarrhythmic complications in patients with Brugada syndrome caused by SCN5A gene mutations. J. Am. Coll. Cardiol. 46 (2005), 2100–2106.
114. [114] Bezzina, C.R., Barc, J., Mizusawa, Y., Remme, C.A., Gourraud, J.B., Simonet, F., Verkerk, A.O., Schwartz, P.J., Crotti, L., Dagradi, F., Guicheney, P., Fressart, V., Leenhardt, A., Antzelevitch, C., Bartkowiak, S., Borggrefe, M., Schimpf, R., Schulze-Bahr, E., Zumhagen, S., Behr, E.R., Bastiaenen, R., Tfelt-Hansen, J., Olesen, M.S., Kaab, S., Beckmann, B.M., Weeke, P., Watanabe, H., Endo, N., Minamino, T., Horie, M., Ohno, S., Hasegawa, K., Makita, N., Nogami, A., Shimizu, W., Aiba, T., Froguel, P., Balkau, B., Lantieri, O., Torchio, M., Wiese, C., Weber, D., Wolswinkel, R., Coronel, R., Boukens, B.J., Bezieau, S., Charpentier, E., Chatel, S., Despres, A., Gros, F., Kyndt, F., Lecointe, S., Lindenbaum, P., Portero, V., Violleau, J., Gessler, M., Tan, H.L., Roden, D.M., Christoffels, V.M., Marec, H.L., Wilde, A.A., Probst, V., Schott, J.J., Dina, C., Redon, R., Common variants at SCN5A–SCN10A and HEY2 are associated with brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat. Genet. 45 (2013), 1044–1049.
115. [115] Hu, D., Barajas-Martinez, H., Pfeiffer, R., Dezi, F., Pfeiffer, J., Buch, T., Betzenhauser, M.J., Belardinelli, L., Kahlig, K.M., Rajamani, S., DeAntonio, H.J., Myerburg, R.J., Ito, H., Deshmukh, P., Marieb, M., Nam, G.B., Bhatia, A., Hasdemir, C., Haissaguerre, M., Veltmann, C., Schimpf, R., Borggrefe, M., Viskin, S., Antzelevitch, C., Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. J. Am. Coll. Cardiol. 64 (2014), 66–79.
116. [116] Holm, H., Gudbjartsson, D.F., Arnar, D.O., Thorleifsson, G., Thorgeirsson, G., Stefansdottir, H., Gudjonsson, S.A., Jonasdottir, A., Mathiesen, E.B., Njolstad, I., Nyrnes, A., Wilsgaard, T., Hald, E.M., Hveem, K., Stoltenberg, C., Lochen, M.L., Kong, A., Thorsteinsdottir, U., Stefansson, K., Several common variants modulate heart rate, PR interval and QRS duration. Nat. Genet. 42 (2010), 117–U140.
117. [117] Baruteau, A.E., Probst, V., Abriel, H., Inherited progressive cardiac conduction disorders. Curr. Opin. Cardiol. 30 (2015), 33–39.
118. [118] Haufe, V., Chamberland, C., Dumaine, R., The promiscuous nature of the cardiac sodium current. J. Mol. Cell. Cardiol. 42 (2007), 469–477.
119. [119] Maier, S.K., Westenbroek, R.E., Schenkman, K.A., Feigl, E.O., Scheuer, T., Catterall, W.A., An unexpected role for brain-type sodium channels in coupling of cell surface depolarization to contraction in the heart. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 4073–4078.
120. [120] Zimmer, T., Haufe, V., Blechschmidt, S., Voltage-gated sodium channels in the mammalian heart. Glob. Cardiol. Sci. Pract. 2014 (2014), 449–463.
121. [121] Gaborit, N., Le Bouter, S., Szuts, V., Varro, A., Escande, D., Nattel, S., Demolombe, S., Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. J. Physiol. 582 (2007), 675–693.
122. [122] Du, Y., Huang, X., Wang, T., Han, K., Zhang, J., Xi, Y., Wu, G., Ma, A., Downregulation of neuronal sodium channel subunits Nav1.1 and Nav1.6 in the sinoatrial node from volume-overloaded heart failure rat. Pflugers Arch. - Eur. J. Physiol. 454 (2007), 451–459.
123. [123] Lei, M., Jones, S.A., Liu, J., Lancaster, M.K., Fung, S.S., Dobrzynski, H., Camelliti, P., Maier, S.K., Noble, D., Boyett, M.R., Requirement of neuronal- and cardiac-type sodium channels for murine sinoatrial node pacemaking. J. Physiol. 559 (2004), 835–848.
124. [124] Maier, S.K., Westenbroek, R.E., Yamanushi, T.T., Dobrzynski, H., Boyett, M.R., Catterall, W.A., Scheuer, T., An unexpected requirement for brain-type sodium channels for control of heart rate in the mouse sinoatrial node. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 3507–3512.
125. [125] Baruscotti, M., DiFrancesco, D., Robinson, R.B., Na(+) current contribution to the diastolic depolarization in newborn rabbit SA node cells. Am. J. Physiol. Heart Circ. Physiol. 279 (2000), H2303–H2309.
126. [126] Furukawa, T., Koumi, S., Sakakibara, Y., Singer, D.H., Jia, H., Arentzen, C.E., Backer, C.L., Wasserstrom, J.A., An analysis of lidocaine block of sodium current in isolated human atrial and ventricular myocytes. J. Mol. Cell. Cardiol. 27 (1995), 831–846.
127. [127] Boukens, B.J., Sylva, M., Vries, C.d.G.-d., Remme, C.A., Bezzina, C.R., Christoffels, V.M., Coronel, R., Reduced sodium channel function unmasks residual embryonic slow conduction in the adult right ventricular outflow tract. Circ. Res. 113 (2013), 137–141.
128. [128] Bezzina, C.R., Rook, M.B., Wilde, A.A., Cardiac sodium channel and inherited arrhythmia syndromes. Cardiovasc. Res. 49 (2001), 257–271.
129. [129] Kim, R.J., Iwai, S., Markowitz, S.M., Shah, B.K., Stein, K.M., Lerman, B.B., Clinical and electrophysiological spectrum of idiopathic ventricular outflow tract arrhythmias. J. Am. Coll. Cardiol. 49 (2007), 2035–2043.
130. [130] Boyett, M.R., Honjo, H., Kodama, I., The sinoatrial node, a heterogeneous pacemaker structure. Cardiovasc. Res. 47 (2000), 658–687.
131. [131] Lei, M., Goddard, C., Liu, J., Leoni, A.L., Royer, A., Fung, S.S., Xiao, G., Ma, A., Zhang, H., Charpentier, F., Vandenberg, J.I., Colledge, W.H., Grace, A.A., Huang, C.L., Sinus node dysfunction following targeted disruption of the murine cardiac sodium channel gene Scn5a. J. Physiol. 567 (2005), 387–400.
132. [132] Baruscotti, M., DiFrancesco, D., Robinson, R.B., A TTX-sensitive inward sodium current contributes to spontaneous activity in newborn rabbit sino-atrial node cells. J. Physiol. 492:Pt 1 (1996), 21–30.
133. [133] Munk, A.A., Adjemian, R.A., Zhao, J., Ogbaghebriel, A., Shrier, A., Electrophysiological properties of morphologically distinct cells isolated from the rabbit atrioventricular node. J. Physiol. 493:Pt 3 (1996), 801–818.
134. [134] Kokubun, S., Nishimura, M., Noma, A., Irisawa, H., Membrane currents in the rabbit atrioventricular node cell. Pflugers Arch. - Eur. J. Physiol. 393 (1982), 15–22.
135. [135] Watanabe, Y., Peculiarities of AV nodal conduction and the role of slow Na current. Jpn. Circ. J. 45 (1981), 446–452.
136. [136] Nikmaram, M.R., Liu, J., Abdelrahman, M., Dobrzynski, H., Boyett, M.R., Lei, M., Characterization of the effects of ryanodine, TTX, E-4031 and 4-AP on the sinoatrial and atrioventricular nodes. Prog. Biophys. Mol. Biol. 96 (2008), 452–464.
137. [137] Dobrzynski, H., Anderson, R.H., Atkinson, A., Borbas, Z., D'Souza, A., Fraser, J.F., Inada, S., Logantha, S.J., Monfredi, O., Morris, G.M., Moorman, A.F., Nikolaidou, T., Schneider, H., Szuts, V., Temple, I.P., Yanni, J., Boyett, M.R., Structure, function and clinical relevance of the cardiac conduction system, including the atrioventricular ring and outflow tract tissues. Pharmacol. Ther. 139 (2013), 260–288.
138. [138] Davies, M.P., Doevendans, P., An, R.H., Kubalak, S., Chien, K.R., Kass, R.S., Developmental changes in ionic channel activity in the embryonic murine heart. Circ. Res. 78 (1996), 15–25.
139. [139] Aanhaanen, W.T., Boukens, B.J., Sizarov, A., Wakker, V., Vries, C.d.G.-d., van Ginneken, A.C., Moorman, A.F., Coronel, R., Christoffels, V.M., Defective Tbx2-dependent patterning of the atrioventricular canal myocardium causes accessory pathway formation in mice. J. Clin. Invest. 121 (2011), 534–544.
140. [140] Cohen, S.A., Immunocytochemical localization of rH1 sodium channel in adult rat heart atria and ventricle. Presence in terminal intercalated disks. Circulation 94 (1996), 3083–3086.
141. [141] Haufe, V., Cordeiro, J.M., Zimmer, T., Wu, Y.S., Schiccitano, S., Benndorf, K., Dumaine, R., Contribution of neuronal sodium channels to the cardiac fast sodium current I-Na is greater in dog heart Purkinje fibers than in ventricles. Cardiovasc. Res. 65 (2005), 117–127.
142. [142] Yu, L., Gao, S., Nie, L., Tang, M., Huang, W., Luo, H., Hu, X., Xi, J., Zhu, M., Zheng, Y., Gao, L., Zhang, L., Song, Y., Hescheler, J., Liang, H., Molecular and functional changes in voltage-gated Na(+) channels in cardiomyocytes during mouse embryogenesis. Circ. J. Off. J. Jpn. Circ. Soc. 75 (2011), 2071–2079.
143. [143] Synnergren, J., Ameen, C., Jansson, A., Sartipy, P., Global transcriptional profiling reveals similarities and differences between human stem cell-derived cardiomyocyte clusters and heart tissue. Physiol. Genomics 44 (2012), 245–258.
144. [144] Mommersteeg, M.T., Hoogaars, W.M., Prall, O.W., Vries, C.d.G.-d., Wiese, C., Clout, D.E., Papaioannou, V.E., Brown, N.A., Harvey, R.P., Moorman, A.F., Christoffels, V.M., Molecular pathway for the localized formation of the sinoatrial node. Circ. Res. 100 (2007), 354–362.
145. [145] Dupays, L., Jarry-Guichard, T., Mazurais, D., Calmels, T., Izumo, S., Gros, D., Theveniau-Ruissy, M., Dysregulation of connexins and inactivation of NFATc1 in the cardiovascular system of Nkx2–5 null mutants. J. Mol. Cell. Cardiol. 38 (2005), 787–798.
146. [146] Satin, J., Kehat, L., Caspi, O., Huber, I., Arbel, G., Itzhaki, I., Magyar, J., Schroder, E.A., Perlman, I., Gepstein, L., Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J. Physiol. Lond. 559 (2004), 479–496.
147. [147] Fatima, A., Kaifeng, S., Dittmann, S., Xu, G., Gupta, M.K., Linke, M., Zechner, U., Nguemo, F., Milting, H., Farr, M., Hescheler, J., Saric, T., The disease-specific phenotype in cardiomyocytes derived from induced pluripotent stem cells of two long QT syndrome type 3 patients. PLoS One, 8, 2013, e83005.
148. [148] Valdivia, C.R., Chu, W.W., Pu, J., Foell, J.D., Haworth, R.A., Wolff, M.R., Kamp, T.J., Makielski, J.C., Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J. Mol. Cell. Cardiol. 38 (2005), 475–483.
149. [149] Otsuji, T.G., Minami, I., Kurose, Y., Yamauchi, K., Tada, M., Nakatsuji, N., Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: qualitative effects on electrophysiological responses to drugs. Stem Cell Res. 4 (2010), 201–213.
150. [150] Ivashchenko, C.Y., Pipes, G.C., Lozinskaya, I.M., Lin, Z., Xiaoping, X., Needle, S., Grygielko, E.T., Hu, E., Toomey, J.R., Lepore, J.J., Willette, R.N., Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype. Am. J. Physiol. Heart Circ. Physiol. 305 (2013), H913–H922.
151. [151] Davies, M.P., An, R.H., Doevendans, P., Kubalak, S., Chien, K.R., Kass, R.S., Developmental changes in ionic channel activity in the embryonic murine heart. Circ. Res. 78 (1996), 15–25.
152. [152] Milstein, M.L., Musa, H., Balbuena, D.P., Anumonwo, J.M., Auerbach, D.S., Furspan, P.B., Hou, L., Hu, B., Schumacher, S.M., Vaidyanathan, R., Martens, J.R., Jalife, J., Dynamic reciprocity of sodium and potassium channel expression in a macromolecular complex controls cardiac excitability and arrhythmia. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), E2134–E2143.
153. [153] Nunes, S.S., Miklas, J.W., Liu, J., Aschar-Sobbi, R., Xiao, Y., Zhang, B., Jiang, J., Masse, S., Gagliardi, M., Hsieh, A., Thavandiran, N., Laflamme, M.A., Nanthakumar, K., Gross, G.J., Backx, P.H., Keller, G., Radisic, M., Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat. Methods 10 (2013), 781–787.
154. [154] Fabiato, A., Calcium-induced release of calcium from the cardiac sarcoplasmic-reticulum. Am. J. Physiol. 245 (1983), C1–C14.
155. [155] Bers, D.M., Cardiac excitation–contraction coupling. Nature 415 (2002), 198–205.
156. [156] Mangoni, M.E., Traboulsie, A., Leoni, A.L., Couette, B., Marger, L., Le Quang, K., Kupfer, E., Cohen-Solal, A., Vilar, J., Shin, H.S., Escande, D., Charpentier, F., Nargeot, J., Lory, P., Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/alpha1G T-type calcium channels. Circ. Res. 98 (2006), 1422–1430.
157. [157] Perez-Reyes, E., Molecular physiology of low-voltage-activated t-type calcium channels. Physiol. Rev. 83 (2003), 117–161.
158. [158] Robert, P.H.B., Rose, A., Calcium Channels in the Heart. Cardiac Electrophysiology. From Cell to Bedside, sixth ed., 2014, 13–22.
159. [159] Chen, F.H., De Diego, C., Chang, M.G., McHarg, J.L., John, S., Klitzner, T.S., Weiss, J.N., Atrioventricular conduction and arrhythmias at the initiation of beating in embryonic mouse hearts. Dev. Dyn. 239 (2010), 1941–1949.
160. [160] Huang, W.F., Tang, M., Role of sodium channels in the spontaneous excitability of early embryonic cardiomyocytes. Chin. J. Physiol. 57 (2014), 188–197.
161. 2 + channel from Cav1.3 to Cav1.2 in embryonic murine ventricle. Circ. J. Off. J. Jpn. Circ. Soc. 69 (2005), 1405–1411.
162. [162] Link, S., Meissner, M., Held, B., Beck, A., Weissgerber, P., Freichel, M., Flockerzi, V., Diversity and developmental expression of L-type calcium channel beta2 proteins and their influence on calcium current in murine heart. J. Biol. Chem. 284 (2009), 30129–30137.
163. 2 + channel in murine hearts during the embryonic period. Am. J. Physiol. Heart Circ. Physiol. 286 (2004), H2257–H2263.
164. 2 + current blocker in single heart cells. Am. J. Physiol. 262 (1992), H463–H471.
165. 2 + channels in human fetal ventricular myocytes. J. Cardiovasc. Electrophysiol. 10 (1999), 692–700.
166. [166] Qu, Y., Boutjdir, M., Gene expression of SERCA2a and L- and T-type Ca channels during human heart development. Pediatr. Res. 50 (2001), 569–574.
167. [167] Kamp, T.J., Hell, J.W., Regulation of cardiac L-type calcium channels by protein kinase a and protein kinase C. Circ. Res. 87 (2000), 1095–1102.
168. 2 +-channel currents in early-stage embryonic mouse heart. Am. J. Physiol. 276 (1999), H608–H613.
169. 2 + exchanger is a determinant of excitation–contraction coupling in human embryonic stem cell-derived ventricular cardiomyocytes. Stem Cells Dev. 19 (2010), 773–782.
170. [170] Ma, J., Guo, L., Fiene, S.J., Anson, B.D., Thomson, J.A., Kamp, T.J., Kolaja, K.L., Swanson, B.J., January, C.T., High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am. J. Physiol. Heart Circ. Physiol. 301 (2011), H2006–H2017.
171. [171] Sartiani, L., Bettiol, E., Stillitano, F., Mugelli, A., Cerbai, E., Jaconi, M.E., Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach. Stem Cells 25 (2007), 1136–1144.
172. [172] Magyar, J., Iost, N., Kortvely, A., Banyasz, T., Virag, L., Szigligeti, P., Varro, A., Opincariu, M., Szecsi, J., Papp, J.G., Nanasi, P.P., Effects of endothelin-1 on calcium and potassium currents in undiseased human ventricular myocytes. Pflugers Arch. - Eur. J. Physiol. 441 (2000), 144–149.
173. [174] Torrente, A.G., Zhang, R., Zaini, A., Giani, J.F., Kang, J., Lamp, S.T., Philipson, K.D., Goldhaber, J.I., Burst pacemaker activity of the sinoatrial node in sodium–calcium exchanger knockout mice. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 9769–9774.
174. + channel mRNA in isolated ferret cardiac myocytes. Circ. Res. 78 (1996), 1083–1089.
175. [176] Wang, Z.G., Yue, L.X., White, M., Pelletier, G., Nattel, S., Differential distribution of inward rectifier potassium channel transcripts in human atrium versus ventricle. Circulation 98 (1998), 2422–2428.
176. [177] Liu, A., Tang, M., Xi, J., Gao, L., Zheng, Y., Luo, H., Hu, X., Zhao, F., Reppel, M., Hescheler, J., Liang, H., Functional characterization of inward rectifier potassium ion channel in murine fetal ventricular cardiomyocytes. Cell. Physiol. Biochem. 26 (2010), 413–420.
177. [178] Schweizer, P.A., Yampolsky, P., Malik, R., Thomas, D., Zehelein, J., Katus, H.A., Koenen, M., Transcription profiling of HCN-channel isotypes throughout mouse cardiac development. Basic Res. Cardiol. 104 (2009), 621–629.
178. + currents in fetal, neonatal, and adult rabbit ventricular myocytes. Circ. Res. 70 (1992), 508–515.
179. [180] Kim, C., Majdi, M., Xia, P., Wei, K.A., Talantova, M., Spiering, S., Nelson, B., Mercola, M., Chen, H.S., Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation. Stem Cells Dev. 19 (2010), 783–795.
180. [181] Zwi, L., Caspi, O., Arbel, G., Huber, I., Gepstein, A., Park, I.H., Gepstein, L., Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120 (2009), 1513–1523.
181. [182] Doss, M.X., Di Diego, J.M., Goodrow, R.J., Wu, Y., Cordeiro, J.M., Nesterenko, V.V., Barajas-Martinez, H., Hu, D., Urrutia, J., Desai, M., Treat, J.A., Sachinidis, A., Antzelevitch, C., Maximum diastolic potential of human induced pluripotent stem cell-derived cardiomyocytes depends critically on I(Kr). PLoS One, 7, 2012, e40288.
182. [183] Caspi, O., Lesman, A., Basevitch, Y., Gepstein, A., Arbel, G., Habib, I.H., Gepstein, L., Levenberg, S., Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ. Res. 100 (2007), 263–272.
183. [184] Gherghiceanu, M., Barad, L., Novak, A., Reiter, I., Itskovitz-Eldor, J., Binah, O., Popescu, L.M., Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure. J. Cell. Mol. Med. 15 (2011), 2539–2551.
184. + embryonic-stem-cell-derived population. Nature 453 (2008), 524–528.
185. [186] Clusin, W.T., Restoring the resting potential brings maturity to induced stem cell-derived human cardiac myocytes. Heart Rhythm. Off. J. Heart Rhythm Soc. 10 (2013), 1911–1912.
186. [187] Herrmann, S., Layh, B., Ludwig, A., Novel insights into the distribution of cardiac HCN channels: an expression study in the mouse heart. J. Mol. Cell. Cardiol. 51 (2011), 997–1006.
187. [188] Fenske, S., Krause, S.C., Hassan, S.I., Becirovic, E., Auer, F., Bernard, R., Kupatt, C., Lange, P., Ziegler, T., Wotjak, C.T., Zhang, H., Hammelmann, V., Paparizos, C., Biel, M., Wahl-Schott, C.A., Sick sinus syndrome in HCN1-deficient mice. Circulation 128 (2013), 2585–2594.
188. [189] Verkerk, A.O., Wilders, R., Pacemaker activity of the human sinoatrial node: an update on the effects of mutations in HCN4 on the hyperpolarization-activated current. Int. J. Mol. Sci. 16 (2015), 3071–3094.
189. [190] Verkerk, A.O., Wilders, R., Pacemaker activity of the human sinoatrial node: effects of HCN4 mutations on the hyperpolarization-activated current. Europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 16, 2014, 384–395.
190. [191] Monfredi, O., Boyett, M.R., Sick sinus syndrome and atrial fibrillation in older persons — a view from the sinoatrial nodal myocyte. J. Mol. Cell. Cardiol. 83 (2015), 88–100.
191. [192] Dias, P., Terracciano, C.M., Hyperpolarization-activated cyclic nucleotide-gated channels and ventricular arrhythmias in heart failure: a novel target for therapy?. J. Am. Heart Assoc., 2, 2013, e000287.
192. [193] Song, G.L., Tang, M., Liu, C.J., Luo, H.Y., Liang, H.M., Hu, X.W., Xi, J.Y., Gao, L.L., Fleischmann, B., Hescheler, J., Developmental changes in functional expression and beta-adrenergic regulation of I(f) in the heart of mouse embryo. Cell Res. 12 (2002), 385–394.
193. [194] Martin, S., Levey, B.A., Levey, G.S., Development of the cardiac beta adrenergic receptor in fetal rat heart. Biochem. Biophys. Res. Commun. 54 (1973), 949–954.
194. [195] Saarikoski, S., Functional development of adrenergic uptake mechanisms in the human fetal heart. Biol. Neonate 43 (1983), 158–163.
195. [196] Fu, J.D., Rushing, S.N., Lieu, D.K., Chan, C.W., Kong, C.W., Geng, L., Wilson, K.D., Chiamvimonvat, N., Boheler, K.R., Wu, J.C., Keller, G., Hajjar, R.J., Li, R.A., Distinct roles of microRNA-1 and -499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes. PLoS One, 6, 2011, e27417.
196. [197] Ma, L.J., Lu, M.F., Schwartz, R.J., Martin, J.F., Bmp2 is essential for cardiac cushion epithelial–mesenchymal transition and myocardial patterning. Development 132 (2005), 5601–5611.
197. [198] Gutman, G.A., Chandy, K.G., Adelman, J.P., Aiyar, J., Bayliss, D.A., Clapham, D.E., Covarriubias, M., Desir, G.V., Furuichi, K., Ganetzky, B., Garcia, M.L., Grissmer, S., Jan, L.Y., Karschin, A., Kim, D., Kuperschmidt, S., Kurachi, Y., Lazdunski, M., Lesage, F., Lester, H.A., McKinnon, D., Nichols, C.G., O'Kelly, I., Robbins, J., Robertson, G.A., Rudy, B., Sanguinetti, M., Seino, S., Stuehmer, W., Tamkun, M.M., Vandenberg, C.A., Wei, A., Wulff, H., Wymore, R.S., International union of pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channels. Pharmacol. Rev. 55 (2003), 583–586.
198. [199] Szabo, G., Szentandrassy, N., Biro, T., Toth, B.I., Czifra, G., Magyar, J., Banyasz, T., Varro, A., Kovacs, L., Nanasi, P.P., Asymmetrical distribution of ion channels in canine and human left-ventricular wall: epicardium versus midmyocardium. Pflugers Arch. - Eur. J. Physiol. 450 (2005), 307–316.
199. [200] Sanguinetti, M.C., Tristani-Firouzi, M., HERG potassium channels and cardiac arrhythmia. Nature 440 (2006), 463–469.
200. [201] Smith, P.L., Baukrowitz, T., Yellen, G., The inward rectification mechanism of the HERG cardiac potassium channel. Nature 379 (1996), 833–836.
201. [202] Teng, G.Q., Zhao, X., Lees-Miller, J.P., Quinn, F.R., Li, P., Rancourt, D.E., London, B., Cross, J.C., Duff, H.J., Homozygous missense N629D hERG (KCNH2) potassium channel mutation causes developmental defects in the right ventricle and its outflow tract and embryonic lethality. Circ. Res. 103 (2008), 1483–1491.
202. [203] Lee, K., Park, J.Y., Ryu, P.D., Kwon, L.S., Kim, H.Y., IKr channel blockers: novel antiarrhythmic agents. Curr. Med. Chem. Cardiovasc. Hematol. Agents 1 (2003), 203–223.
203. [204] Yang, T., Chun, Y.W., Stroud, D.M., Mosley, J.D., Knollmann, B.C., Hong, C., Roden, D.M., Screening for acute IKr block is insufficient to detect torsades de pointes liability: role of late sodium current. Circulation 130 (2014), 224–234.
204. + channels in mouse heart. Circ. Res. 79 (1996), 79–85.
205. [206] Curran, M.E., Splawski, I., Timothy, K.W., Vincent, G.M., Green, E.D., Keating, M.T., A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80 (1995), 795–803.
206. [207] Bhuiyan, Z.A., Momenah, T.S., Gong, Q., Amin, A.S., Ghamdi, S.A., Carvalho, J.S., Homfray, T., Mannens, M.M., Zhou, Z., Wilde, A.A., Recurrent intrauterine fetal loss due to near absence of HERG: clinical and functional characterization of a homozygous nonsense HERG Q1070X mutation. Heart Rhythm. Off. J. Heart Rhythm Soc. 5 (2008), 553–561.
207. [208] Azarbayjani, F., Danielsson, B.R., Embryonic arrhythmia by inhibition of HERG channels: a common hypoxia-related teratogenic mechanism for antiepileptic drugs?. Epilepsia 43 (2002), 457–468.
208. [209] Mehta, A., Chung, Y.Y., Ng, A., Iskandar, F., Atan, S., Wei, H., Dusting, G., Sun, W., Wong, P., Shim, W., Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells. Cardiovasc. Res. 91 (2011), 577–586.
209. [210] Caspi, O., Itzhaki, I., Kehat, I., Gepstein, A., Arbel, G., Huber, I., Satin, J., Gepstein, L., In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. Stem Cells Dev. 18 (2009), 161–172.
210. [211] Wang, K., Terrenoire, C., Sampson, K.J., Iyer, V., Osteen, J.D., Lu, J., Keller, G., Kotton, D.N., Kass, R.S., Biophysical properties of slow potassium channels in human embryonic stem cell derived cardiomyocytes implicate subunit stoichiometry. J. Physiol. 589 (2011), 6093–6104.
211. [212] Liu, J., Backx, P.H., Patch-clamp technique in ESC-derived cardiomyocytes. Methods Mol. Biol. 1181 (2014), 203–214.
212. [213] Lengyel, C., Iost, N., Virag, L., Varro, A., Lathrop, D.A., Papp, J.G., Pharmacological block of the slow component of the outward delayed rectifier current (I(Ks)) fails to lengthen rabbit ventricular muscle QT(c) and action potential duration. Br. J. Pharmacol. 132 (2001), 101–110.
213. [214] Furukawa, T., Ono, Y., Tsuchiya, H., Katayama, Y., Bang, M.L., Labeit, D., Labeit, S., Inagaki, N., Gregorio, C.C., Specific interaction of the potassium channel beta-subunit minK with the sarcomeric protein T-cap suggests a T-tubule-myofibril linking system. J. Mol. Biol. 313 (2001), 775–784.
214. [215] Potet, F., Scott, J.D., Mohammad-Panah, R., Escande, D., Baro, I., AKAP proteins anchor cAMP-dependent protein kinase to KvLQT1/IsK channel complex. Am. J. Physiol. Heart Circ. Physiol. 280 (2001), H2038–H2045.
215. [216] Marx, S.O., Kurokawa, J., Reiken, S., Motoike, H., D'Armiento, J., Marks, A.R., Kass, R.S., Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 295 (2002), 496–499.
216. + current. Differential sensitivity to block by class III antiarrhythmic agents. J. Gen. Physiol. 96 (1990), 195–215.
217. [218] Sanguinetti, M.C., Jurkiewicz, N.K., Scott, A., Siegl, P.K., Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action. Circ. Res. 68 (1991), 77–84.
218. [219] Osteen, J.D., Sampson, K.J., Kass, R.S., The cardiac IKs channel, complex indeed. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 18751–18752.
219. [220] Crotti, L., Spazzolini, C., Porretta, A.P., Dagradi, F., Taravelli, E., Petracci, B., Vicentini, A., Pedrazzini, M., La Rovere, M.T., Vanoli, E., Goosen, A., Heradien, M., George, A.L. Jr., Brink, P.A., Schwartz, P.J., Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. J. Am. Coll. Cardiol. 60 (2012), 2515–2524.
220. [221] Felipe, A., Knittle, T.J., Doyle, K.L., Snyders, D.J., Tamkun, M.M., Differential expression of Isk mRNAs in mouse tissue during development and pregnancy. Am. J. Physiol. 267 (1994), C700–C705.
221. [222] Niwa, N., Nerbonne, J.M., Molecular determinants of cardiac transient outward potassium current (I(to)) expression and regulation. J. Mol. Cell. Cardiol. 48 (2010), 12–25.
222. [223] Liu, J., Kim, K.H., London, B., Morales, M.J., Backx, P.H., Dissection of the voltage-activated potassium outward currents in adult mouse ventricular myocytes: I(to,f), I(to,s), I(K,slow1), I(K,slow2), and I(ss). Basic Res. Cardiol. 106 (2011), 189–204.
223. [224] Liu, J., Kim, K.H., Morales, M.J., Heximer, S.P., Hui, C.C., Backx, P.H., Kv4.3-encoded fast transient outward current is presented in Kv4.2 knockout mouse cardiomyocytes. PLoS One, 10, 2015, e0133274.
224. [225] Deschenes, I., DiSilvestre, D., Juang, G.J., Wu, R.C., An, W.F., Tomaselli, G.F., Regulation of Kv4.3 current by KChIP2 splice variants: a component of native cardiac I(to)?. Circulation 106 (2002), 423–429.
225. [226] Hashimoto, Y., Nunoki, K., Kudo, H., Ishii, K., Taira, N., Yanagisawa, T., Changes in the inactivation of rat Kv1.4 K(+) channels induced by varying the number of inactivation particles. J. Biol. Chem. 275 (2000), 9358–9362.
226. [227] Kassiri, Z., Zobel, C., Nguyen, T.T., Molkentin, J.D., Backx, P.H., Reduction of I(to) causes hypertrophy in neonatal rat ventricular myocytes. Circ. Res. 90 (2002), 578–585.
227. + channel isoforms in rat ventricle. J. Physiol. 500:Pt 1 (1997), 65–73.
228. [229] Cordeiro, J.M., Greene, L., Heilmann, C., Antzelevitch, D., Antzelevitch, C., Transmural heterogeneity of calcium activity and mechanical function in the canine left ventricle. Am. J. Physiol. Heart Circ. Physiol. 286 (2004), H1471–H1479.
229. + current changes and action potential duration. J. Am. Coll. Cardiol. 41 (2003), 1611–1622.
230. + channel currents in rat ventricular myocytes. J. Gen. Physiol. 108 (1996), 405–419.
231. [232] Matsubara, H., Suzuki, J., Inada, M., Shaker-related potassium channel, Kv1.4, mRNA regulation in cultured rat heart myocytes and differential expression of Kv1.4 and Kv1.5 genes in myocardial development and hypertrophy. J. Clin. Invest., 92(1993), 1659–1666.
232. [233] London, B., Wang, D.W., Hill, J.A., Bennett, P.B., The transient outward current in mice lacking the potassium channel gene Kv1.4. J. Physiol. 509 (1998), 171–182 Pt 1.
233. [234] Blaustein, M.P., Lederer, W.J., Sodium/calcium exchange: its physiological implications. Physiol. Rev. 79 (1999), 763–854.
234. [235] Weber, C.R., Piacentino, V. 3rd, Ginsburg, K.S., Houser, S.R., Bers, D.M., Na(+)–Ca(2 +) exchange current and submembrane [Ca(2 +)] during the cardiac action potential. Circ. Res. 90 (2002), 182–189.
235. 2 + exchanger during development in human heart. Cardiovasc. Res. 45 (2000), 866–873.
236. 2 + exchanger gene leads to cardiomyocyte apoptosis and defects in heartbeat. J. Biol. Chem. 275 (2000), 36991–36998.
237. [239] Liu, J., Fu, J.D., Siu, C.W., Li, R.A., Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. Stem Cells 25 (2007), 3038–3044.
238. [240] Mummery, C.L., Zhang, J., Ng, E.S., Elliott, D.A., Elefanty, A.G., Kamp, T.J., Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ. Res. 111 (2012), 344–358.
239. [241] Kadota, S., Minami, I., Morone, N., Heuser, J.E., Agladze, K., Nakatsuji, N., Development of a reentrant arrhythmia model in human pluripotent stem cell-derived cardiac cell sheets. Eur. Heart J. 34 (2013), 1147–1156.
240. [242] Laposa, R.R., Stem cells for drug screening. J. Cardiovasc. Pharmacol. 58 (2011), 240–245.
241. [243] Braam, S.R., Tertoolen, L., van de Stolpe, A., Meyer, T., Passier, R., Mummery, C.L., Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res. 4 (2010), 107–116.
242. [244] Chan, Y.C., Ting, S., Lee, Y.K., Ng, K.M., Zhang, J., Chen, Z., Siu, C.W., Oh, S.K., Tse, H.F., Electrical stimulation promotes maturation of cardiomyocytes derived from human embryonic stem cells. J. Cardiovasc. Transl. Res. 6 (2013), 989–999.
243. [245] Nattel, S., Maguy, A., Le Bouter, S., Yeh, Y.H., Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol. Rev. 87 (2007), 425–456.
244. [246] Nerbonne, J.M., Kass, R.S., Molecular physiology of cardiac repolarization. Physiol. Rev. 85 (2005), 1205–1253.
245. [247] Rees, S.A., Curtis, M.J., Specific IK1 blockade: a new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit, and primate. Circulation 87 (1993), 1979–1989.
246. [248] Takanari, H., Nalos, L., Stary-Weinzinger, A., de Git, K.C., Varkevisser, R., Linder, T., Houtman, M.J., Peschar, M., de Boer, T.P., Tidwell, R.R., Rook, M.B., Vos, M.A., van der Heyden, M.A., Efficient and specific cardiac IK(1) inhibition by a new pentamidine analogue. Cardiovasc. Res. 99 (2013), 203–214.
247. [249] Kambouris, N.G., Nuss, H.B., Johns, D.C., Marban, E., Tomaselli, G.F., Balser, J.R., A revised view of cardiac sodium channel “blockade” in the long-QT syndrome. J. Clin. Invest. 105 (2000), 1133–1140.
248. [250] Levine, T.B., Bernink, P.J., Caspi, A., Elkayam, U., Geltman, E.M., Greenberg, B., McKenna, W.J., Ghali, J.K., Giles, T.D., Marmor, A., Reisin, L.H., Ammon, S., Lindberg, E., Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality assessment in congestive heart failure trial. Circulation 101 (2000), 758–764.
249. [251] Kim, H.J., Ahn, H.S., Choi, J.S., Choi, B.H., Hahn, S.J., Effects of ranolazine on cloned cardiac kv4.3 potassium channels. J. Pharmacol. Exp. Ther. 339 (2011), 952–958.
250. [252] Sanguinetti, M.C., Johnson, J.H., Hammerland, L.G., Kelbaugh, P.R., Volkmann, R.A., Saccomano, N.A., Mueller, A.L., Heteropodatoxins: peptides isolated from spider venom that block Kv4.2 potassium channels. Mol. Pharmacol. 51 (1997), 491–498.
251. [253] Ehrlich, J.R., Biliczki, P., Hohnloser, S.H., Nattel, S., Atrial-selective approaches for the treatment of atrial fibrillation. J. Am. Coll. Cardiol. 51 (2008), 787–792.
252. [254] Jilkina, O., Kuzio, B., Grover, G.J., Kupriyanov, V.V., Cardioselective sulfonylthiourea HMR 1098 blocks mitochondrial uncoupling induced by a KATP channel opener, P-1075, in beating rat hearts. Biochim. Biophys. Acta 1638 (2003), 121–128.
253. [255] Gandhi, A., Siedlecka, U., Shah, A.P., Navaratnarajah, M., Yacoub, M.H., Terracciano, C.M., The effect of SN-6, a novel sodium–calcium exchange inhibitor, on contractility and calcium handling in isolated failing rat ventricular myocytes. Cardiovasc. Ther. 31 (2013), e115–e124.
254. [256] Katz, A., Lifshitz, Y., Bab-Dinitz, E., Kapri-Pardes, E., Goldshleger, R., Tal, D.M., Karlish, S.J., Selectivity of digitalis glycosides for isoforms of human Na,K-ATPase. J. Biol. Chem. 285 (2010), 19582–19592.
255. [257] Protze, S., Khattak, S., Poulet, C., Lindemann, D., Tanaka, E.M., Ravens, U., A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J. Mol. Cell. Cardiol. 53 (2012), 323–332.
256. [258] Poulet, C., Wettwer, E., Grunnet, M., Jespersen, T., Fabritz, L., Matschke, K., Knaut, M., Ravens, U., Late sodium current in human atrial cardiomyocytes from patients in sinus rhythm and atrial fibrillation. PLoS One, 10, 2015, e0131432.
257. + current in rabbit sinoatrial node cells. Cardiovasc. Res. 46 (2000), 433–441.
258. + current similar to Kv1.5 cloned channel currents. Circ. Res. 73 (1993), 1061–1076.
259. [261] Zhang, H., Flagg, T.P., Nichols, C.G., Cardiac sarcolemmal K(ATP) channels: latest twists in a questing tale!. J. Mol. Cell. Cardiol. 48 (2010), 71–75.
260. [262] Cordeiro, J.M., Zeina, T., Goodrow, R., Kaplan, A.D., Thomas, L.M., Nesterenko, V.V., Treat, J.A., Hawel, L. 3rd, Byus, C., Bett, G.C., Rasmusson, R.L., Panama, B.K., Regional variation of the inwardly rectifying potassium current in the canine heart and the contributions to differences in action potential repolarization. J. Mol. Cell. Cardiol. 84 (2015), 52–60.
261. [263] Spater, D., Hansson, E.M., Zangi, L., Chien, K.R., How to make a cardiomyocyte. Development 141 (2014), 4418–4431.
262. [264] Robertson, C., Tran, D.D., George, S.C., Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes. Stem Cells 31 (2013), 829–837.
263. [265] Drouin, E., Charpentier, F., Gauthier, C., Laurent, K., Lemarec, H., Electrophysiologic characteristics of cells spanning the left-ventricular wall of human heart — evidence for presence of M-cells. J. Am. Coll. Cardiol. 26 (1995), 185–192.
264. [266] Smolich, J.J., Ultrastructural and functional features of the developing mammalian heart: a brief overview. Reprod. Fertil. Dev. 7 (1995), 451–461.
265. [267] Rana, P., Anson, B., Engle, S., Will, Y., Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening. Toxicol. Sci. 130 (2012), 117–131.
266. [268] Hattori, F., Chen, H., Yamashita, H., Tohyama, S., Satoh, Y., Yuasa, S., Li, W.Z., Yamakawa, H., Tanaka, T., Onitsuka, T., Shimoji, K., Ohno, Y., Egashira, T., Kaneda, R., Murata, M., Hidaka, K., Morisaki, T., Sasaki, E., Suzuki, T., Sano, M., Makino, S., Oikawa, S., Fukuda, K., Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat. Methods, 7, 2010 61-U15.
267. [269] Lopaschuk, G.D., Spafford, M.A., Marsh, D.R., Glycolysis is predominant source of myocardial Atp production immediately after birth. Am. J. Physiol. 261 (1991), H1698–H1705.
268. [270] Turnbull, I.C., Karakikes, I., Serrao, G.W., Backeris, P., Lee, J.J., Xie, C., Senyei, G., Gordon, R.E., Li, R.A., Akar, F.G., Hajjar, R.J., Hulot, J.S., Costa, K.D., Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. FASEB J. 28 (2014), 644–654.
269. [271] Hasenfuss, G., Mulieri, L.A., Blanchard, E.M., Holubarsch, C., Leavitt, B.J., Ittleman, F., Alpert, N.R., Energetics of isometric force development in control and volume-overload human myocardium. Comparison with animal species. Circ. Res. 68 (1991), 836–846.
270. 2 + wavefronts in mouse and human embryonic stem cell-derived cardiomyocytes. Stem Cells Dev. 18 (2009), 1493–1500.
271. [273] Satin, J., Itzhaki, I., Rapoport, S., Schroder, E.A., Izu, L., Arbel, G., Beyar, R., Balke, C.W., Schiller, J., Gepstein, L., Calcium handling in human embryonic stem cell-derived cardiomyocytes. Stem Cells 26 (2008), 1961–1972.
272. [274] Kehat, I., Gepstein, A., Spira, A., Itskovitz-Eldor, J., Gepstein, L., High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes — a novel in vitro model for the study of conduction. Circ. Res. 91 (2002), 659–661.
273. [275] Nanthakumar, K., Jalife, J., Masse, S., Downar, E., Pop, M., Asta, J., Ross, H., Rao, V., Mironov, S., Sevaptsidis, E., Rogers, J., Wright, G., Dhopeshwarkar, R., Optical mapping of Langendorff-perfused human hearts: establishing a model for the study of ventricular fibrillation in humans. Am. J. Physiol. Heart C 293 (2007), H875–H880.
274. [276] Drouin, E., Lande, G., Charpentier, F., Amiodarone reduces transmural heterogeneity of repolarization in the human heart. J. Am. Coll. Cardiol. 32 (1998), 1063–1067.
275. [277] Dan, P., Zeng, Z., Li, Y., Qu, Y., Hove-Madsen, L., Tibbits, G.F., Phenotype-dependent role of the L-type calcium current in embryonic stem cell derived cardiomyocytes. Am. J. Stem Cells 3 (2014), 37–45.
276. [278] Pelzmann, B., Schaffer, P., Bernhart, E., Lang, P., Machler, H., Rigler, B., Koidl, B., L-type calcium current in human ventricular myocytes at a physiological temperature from children with tetralogy of Fallot. Cardiovasc. Res. 38 (1998), 424–432.
277. [279] Wang, Z., Fermini, B., Nattel, S., Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc. Res. 28 (1994), 1540–1546.
278. [280] Zahler, R., Sun, W., Ardito, T., Kashgarian, M., Na–K-ATPase alpha-isoform expression in heart and vascular endothelia: cellular and developmental regulation. Am. J. Physiol. 270 (1996), C361–C371.
279. [281] Fine, M., Lu, F.M., Lin, M.J., Moe, O., Wang, H.R., Hilgemann, D.W., Human-induced pluripotent stem cell-derived cardiomyocytes for studies of cardiac ion transporters. Am. J. Physiol. Cell Physiol. 305 (2013), C481–C491.
280. [282] Bosman, A., Sartiani, L., Spinelli, V., Del Lungo, M., Stillitano, F., Nosi, D., Mugelli, A., Cerbai, E., Jaconi, M., Molecular and functional evidence of HCN4 and caveolin-3 interaction during cardiomyocyte differentiation from human embryonic stem cells. Stem Cells Dev. 22 (2013), 1717–1727.
281. [283] Lee, Y.K., Ng, K.M., Lai, W.H., Chan, Y.C., Lau, Y.M., Lian, Q., Tse, H.F., Siu, C.W., Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Rev. 7 (2011), 976–986.
282. [284] Peng, S., Lacerda, A.E., Kirsch, G.E., Brown, A.M., Bruening-Wright, A., The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes. J. Pharmacol. Toxicol. Methods 61 (2010), 277–286.
283. [285] Moore, J.C., Fu, J., Chan, Y.C., Lin, D., Tran, H., Tse, H.F., Li, R.A., Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent state. Biochem. Biophys. Res. Commun. 372 (2008), 553–558.